Company Overview

Endexx Corporation (OTCQB: EDXC) is a U.S.-based consumer products and wellness company focused on cannabidiol (CBD), plant-based health products, and related consumer packaged goods. The company operates primarily in the health and wellness industry through branded CBD products, topical formulations, supplements, and consumer wellness offerings. Public filings and company disclosures indicate that Endexx has historically pursued opportunities tied to hemp-derived cannabinoids, nutraceuticals, and alternative wellness markets, while also exploring technology-enabled retail and distribution initiatives.

The company’s principal revenue drivers have centered on CBD consumer products sold through retail, wholesale, and e-commerce channels. Endexx has marketed products under brands including CBD Unlimited and related wellness lines. Its customer base includes health-conscious consumers, specialty retailers, wellness distributors, and online purchasers primarily in the United States. Endexx evolved from earlier business activities into a cannabinoid-focused wellness company following changes in U.S. hemp and CBD market regulations, particularly after the broader legalization of hemp-derived products under U.S. federal law. Public information regarding some historical operating transitions and inactive business lines varies across disclosures, and certain historical details are inconclusive based on available public sources.

Business Operations

Endexx generates revenue primarily through the sale and distribution of CBD-based consumer products and wellness solutions. The company’s operating structure has included branded product development, manufacturing coordination, packaging, marketing, and retail distribution. Public filings identify CBD Unlimited as a core operating brand associated with topical creams, tinctures, capsules, gummies, and other hemp-derived wellness products. The company has also referenced technology-enabled distribution initiatives and retail-focused strategies in prior investor communications.

Operations have been concentrated mainly in the United States, though the company has indicated interest in broader international wellness and cannabinoid markets. Endexx relies on supply chain relationships, formulation expertise, branding, and distribution partnerships rather than large-scale vertically integrated agricultural assets. Publicly available filings do not consistently identify material international joint ventures or large controlled subsidiaries beyond its branded wellness operations. Some operational details regarding manufacturing relationships and active partnerships are limited in current public disclosures.

Strategic Position & Investments

Endexx’s strategic direction has focused on expanding participation in the regulated hemp-derived wellness market through branded consumer products, distribution growth, and product diversification. Company disclosures have emphasized efforts to strengthen retail penetration, broaden e-commerce channels, and develop differentiated wellness offerings in categories such as pain relief, recovery, and daily health supplements. The company has also highlighted opportunities tied to increasing consumer acceptance of hemp-derived cannabinoids and alternative wellness products.

Historically, Endexx has pursued acquisitions, licensing arrangements, and investments intended to expand its product portfolio and market reach, including activities associated with CBD Unlimited and related consumer wellness brands. Public disclosures also reference interest in emerging sectors tied to cannabinoid innovation, functional wellness, and plant-based health products. However, the scale and financial impact of several announced initiatives are difficult to independently verify through recent public filings, and some previously announced strategic initiatives appear to have evolved or become inactive over time.

Geographic Footprint

Endexx is headquartered in the United States, with operations and sales activity primarily focused on domestic markets. Its products have been distributed through online channels, wellness retailers, and specialty distribution networks across multiple U.S. regions. Public disclosures indicate that the company has sought broader exposure in the expanding North American CBD and wellness sector.

The company has periodically referenced international opportunities and global wellness market expansion, particularly in regions where cannabinoid-related consumer products have gained regulatory acceptance. However, publicly verified information regarding substantial operating infrastructure or material revenue generation outside the United States remains limited. Data regarding large-scale international operational influence is inconclusive based on available public sources.

Leadership & Governance

Endexx operates as a publicly traded company subject to U.S. reporting requirements, including disclosures filed through the SEC and OTC market reporting systems. Leadership has emphasized growth through branded wellness products, cannabinoid market participation, and consumer health innovation. Governance and strategic execution appear focused on maintaining operational flexibility in a highly regulated and evolving industry environment.

Key executives identified in public filings and company disclosures include:

• Todd Davis – Chief Executive Officer
• Todd Davis – Chairman
• Richard Bastiani – Chief Financial Officer

Public records indicate that leadership has prioritized product commercialization, retail expansion, and positioning the company within the broader hemp-derived wellness industry. Certain historical leadership and board composition details vary across reporting periods and may not be consistently updated across all public sources.